![Timber Pharmaceuticals Inc](/common/images/company/A_TMBR.png)
WARREN, NJ, Nov. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and...
WARREN, NJ, Sept. 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company...
Transaction Provides Timber Stockholders with Upfront Cash Consideration and Downstream Value through Contingent Value RightsTotal Transaction Value of up to $36 millionTransaction Expected to...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | -1.3574 | -79.8470588235 | 1.7 | 3.36 | 0.3202 | 319124 | 2.53702239 | CS |
156 | -52.1574 | -99.3474285714 | 52.5 | 56 | 0.3202 | 2590461 | 10.36046876 | CS |
260 | -205.1574 | -99.8332846715 | 205.5 | 208.5 | 0.3202 | 2794904 | 44.07708733 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.